Skip to main content
. Author manuscript; available in PMC: 2016 Oct 1.
Published in final edited form as: Pharm Res. 2015 May 6;32(10):3170–3187. doi: 10.1007/s11095-015-1695-1

Figure 1.

Figure 1

Inhalation waveforms consistent with the selected in vivo datasets. The waveform used with the Novolizer DPI is characterized as “quick and deep” (QD) inhalation and the waveform used with the Respimat SMI is characterized as “slow and deep” (SD) inhalation.